Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3. Blobner J, Ruf V, Weller J, Teske N, et al. J Neurooncol 2025;175:763-774.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blobner J, Ruf V, Weller J, Teske N, et al. Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3. J Neurooncol 2025;175:763-774.
PMID: 40702387